NCT05178264View on ClinicalTrials.gov

Transverse Myelitis Related to SARS-CoV-2 Vaccines

CompletedOBSERVATIONAL
Enrollment

580

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions
Vaccine Adverse Reaction
Interventions
DRUG

SARS-CoV-2 vaccines

All patients treated at least with 1 SARS-CoV-2 vaccine

Trial Locations (1)

14000

Alexandre Joachim, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT05178264 - Transverse Myelitis Related to SARS-CoV-2 Vaccines | Biotech Hunter | Biotech Hunter